A Clinical Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Administered Beyond Release Criteria in Subjects with Relapsed/Refractory B‑Cell Non‑Hodgkin Lymphoma (ChiCTR) - Oct 16, 2026 - P4 | N=25 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University
New P4 trial • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Follicular Lymphoma • Hematological Malignancies • Large B Cell Lymphoma • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|